Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck.
Min Hee HongChang Gon KimYoon Woo KohEun Chang ChoiJinna KimSun Och YoonChang Gon KimByoung Chul ChoPublished in: Head & neck (2017)
Administering vinorelbine plus cisplatin chemotherapy to patients with recurrent and/or metastatic salivary gland cancers is safe and effective.